Depression News and Research

Latest Depression News and Research

Valdoxan - a melatonergic antidepressant - receives positive European opinion for major depressive disorder

The first melatonergic antidepressant - Valdoxan/Thymanax (agomelatine) - has received a positive opinion from the European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) for its use in the treatment of adult patients with major depressive disorder (MDD).

21 Nov 2008

FDA approves tapentadol immediate-release tablets for pain in adults

Millions of Americans with moderate to severe acute pain and their health-care providers will soon have a new treatment option.

21 Nov 2008

Bipolar disorder genes, pathways identified

Neuroscientists at the Indiana University School of Medicine have created the first comprehensive map of genes likely to be involved in bipolar disorder, according to research published online Nov. 21 in the American Journal of Medical Genetics.

21 Nov 2008

FDA approves Banzel (rufinamide) for Lennox-Gastaut syndrome

The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.

20 Nov 2008

Patients at risk of self-harm after discharge from psychiatric care

Non-fatal self-harm may occur in over ten per cent of adults discharged from psychiatric inpatient care in England and Wales, according to new research from the University of Bristol published in the BMJ. The risk was found to be greatest in the first month, Professor David Gunnell and colleagues found.

20 Nov 2008

Stress found to impair decision making in rats

Neuroscientists from the University of Washington have found that a single exposure to uncontrollable stress impairs decision making in rats for several days, making them unable to reliably seek out the larger of two rewards.

18 Nov 2008

Patients with depressive disorders or schizophrenia more likely to re-attempt suicide

Men and women who have tried to kill themselves and are suffering from unipolar disorder (major depression), bipolar disorder (manic depression) or schizophrenia are at a very high risk of committing suicide within a year of their first attempt, concludes a study published today on bmj.com.

18 Nov 2008

Crystal meth abuse linked to underage sex, smoking and drinking

Teens who have never done drugs, but engage in other risky behaviours such as drinking, smoking and being sexually active, are more likely to use crystal meth, medical researchers at the University of Alberta have concluded.

18 Nov 2008

Exercise after bariatric surgery can yield better postoperative outcomes

A new study by researchers from The Miriam Hospital's Centers for Behavioral and Preventive Medicine suggests increased physical activity after bariatric surgery can yield better postoperative outcomes.

17 Nov 2008

Vitamin D deficiency may be a culprit in heart disease, high blood pressure and metabolic syndrome

The temperature might not be the only thing plummeting this winter.

17 Nov 2008

Negative thinking may play a bigger role in heart failure than previously thought

Researchers at the University of Kentucky found that patients who had negative thinking patterns, such as thoughts about not being able to justify their own existence, were at higher risk for developing depression.

16 Nov 2008

No clear evidence that depression screening improves cardiovascular patients' health

Results of a new study call into question recent clinical guidelines issued by leading cardiovascular groups, including the American Heart Association, which recommend patients with cardiovascular disease be screened for signs of depression and treated accordingly.

16 Nov 2008

Breakthrough in cellular analysis

Like skilled assassins, many diseases seem to know exactly what types of cells to attack.

16 Nov 2008

Breakthrough in cell-type analysis offers new ways to study development and disease

Like skilled assassins, many diseases seem to know exactly what types of cells to attack. While decimating one cadre of cells, diseases will inexplicably spare a seemingly identical group of neighbors. What makes cells vulnerable or not depends largely on the kinds and amounts of proteins they produce - their 'translational profile,' in the lingo of molecular biology. For this reason, scientists have struggled to parse the subtle molecular differences among the hundreds of specialized cell types that are tangled together in tissues like the brain.

13 Nov 2008